Venture Investors Turn To AI To Find Deal

Predictive language models' underlying function more closely resembles the human brain

Investors love data. So why not dig into sustainability metrics?

AI drug discovery platform raises Series B funding

UK life science attracts £850m deal

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Cambridge-1 and the future of medicine

AI startups notched another big quarter in a record-breaking year for global funding, mega-rounds, unicorns, exits, and more.

Analysts compile top European biotech news of 2021

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement